Skip to main content

Scientists Spot Cause of Lupus, Way to Reverse It

Medically reviewed by Carmen Pope, BPharm. Last updated on July 11, 2024.

By Dennis Thompson HealthDay Reporter

THURSDAY, July 11, 2024 -- Lupus is caused by a specific defect in the immune system that can be reversed, potentially curing the autoimmune disorder, a new study claims.

The disease appears to be caused by malfunctions in an immune system pathway that regulates cells’ response to environmental pollutants, bacteria and toxins.

Insufficient activation of this pathway, controlled by the aryl hydrocarbon receptor (AHR), results in an overproduction of immune cells that attack the body itself rather than foreign invaders, researchers said.

By fully activating this immune system response, “we can reduce the number of these disease-causing cells,” said researcher Dr. Jaehyuk Choi, an associate professor of dermatology at Northwestern University Feinberg School of Medicine.

“If these effects are durable, this may be a potential cure,” Choi added in a Northwestern news release.

Lupus occurs when the immune system turns on the body, causing systemic inflammation that can result in life-threatening damage to organs like the kidneys, heart, and brain.

Existing treatments have focused on suppressing the immune system, which left patients vulnerable to dangerous infections.

“Up until this point, all therapy for lupus is a blunt instrument. It’s broad immunosuppression,” Choi said. “By identifying a cause for this disease, we have found a potential cure that will not have the side effects of current therapies.”

To test if this pathway drives lupus, researchers tested AHR-activating drugs on blood samples taken from lupus patients.

This treatment seemed to reprogram the lupus-causing cells into cells that might instead promote wound healing, researchers reported July 10 in the journal Nature.

“We’ve identified a fundamental imbalance in the immune responses that patients with lupus make, and we’ve defined specific mediators that can correct this imbalance to dampen the pathologic autoimmune response,” researcher Dr. Deepak Rao, a rheumatologist at Brigham and Women’s Hospital in Boston, said in a news release.

The next step is to use this knowledge to make new treatments for lupus patients using AHR-activating drugs, researchers said.

Sources

  • Northwestern University, news release, July 10, 2024

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted July 2024

Read this next

Lupus, Type 1 Diabetes Linked to Pregnancy Complications

WEDNESDAY, March 20, 2024 -- People with autoimmune disorders such as lupus, type 1 diabetes and rheumatoid arthritis tend to have fewer children, and women with this class of...

COVID Might Raise Odds for Immune Disorders Like Crohn's, Alopecia

TUESDAY, Oct. 10, 2023 -- In rare cases, some patients may develop an autoimmune disease following a bout of COVID, Korean researchers report. Conditions such as alopecia (hair...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.